Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients Meeting Abstract
| Authors: | Awada, A. H.; Harding, J. J.; Kotecki, N.; Aftimos, P. G.; Decaens, T.; Dreyer, C.; Ansaldi, C.; Rachid, M.; Serdjebi, C.; Halfon, P.; Abou-Alfa, G. K.; Raymond, E. |
| Abstract Title: | Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz247.072 |
| Language: | English |
| ACCESSION: | WOS:000491295502174 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz247.072 |
| Notes: | Meeting Abstract: 745P -- Appears on page v286 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
